REGULATED PRESS RELEASE published on 05/06/2024 at 17:35, 6 months 15 days ago Disclosure of transactions in own shares on May 2 to May 3, 2024
REGULATED PRESS RELEASE published on 04/30/2024 at 19:00, 6 months 21 days ago Disclosure of transactions in own shares on April 22 to April 30, 2024
REGULATED PRESS RELEASE published on 04/22/2024 at 17:35, 6 months 29 days ago Disclosure of transactions in own shares on April 15 to April 19, 2024
REGULATED PRESS RELEASE published on 04/15/2024 at 17:35, 7 months 6 days ago Disclosure of transactions in own shares on April 8 to April 12, 2024
BRIEF published on 04/09/2024 at 17:40, 7 months 12 days ago Eurazeo Announces Share Capital and Voting Rights as of March 31, 2024 Share Capital Voting Rights EURAZEO Treasury Shares AMF Regulation
REGULATED PRESS RELEASE published on 04/09/2024 at 17:35, 7 months 12 days ago Disclosure of the number of shares and the total number of voting rights as of March 31, 2024 Eurazeo discloses total shares and voting rights for March 31, 2024, in compliance with regulations. The leading European investment group manages diversified assets and supports companies globally Voting Rights Shares EURAZEO Investment Group Regulations
REGULATED PRESS RELEASE published on 04/08/2024 at 17:35, 7 months 13 days ago Disclosure of transactions in own shares on April 2 to April 5, 2024
BRIEF published on 04/03/2024 at 17:50, 7 months 18 days ago EURAZEO Completes Sale of DORC to Carl Zeiss Meditec AG EURAZEO Medical Technology Carl Zeiss Meditec AG DORC Investment Return
REGULATED PRESS RELEASE published on 04/03/2024 at 17:45, 7 months 18 days ago EURAZEO COMPLETES THE SALE OF DORC TO CARL ZEISS MEDITEC AG Eurazeo completes sale of DORC to Carl Zeiss Meditec AG, a leading medical technology company, generating 2.6x cash-on-cash return. Transaction showcases successful mid-large buyout playbook in the healthcare sector Healthcare Sector EURAZEO Investment Carl Zeiss Meditec AG DORC
REGULATED PRESS RELEASE published on 03/29/2024 at 17:35, 7 months 23 days ago Disclosure of transactions in own shares on March 25 to March 28, 2024
Published on 11/22/2024 at 09:00, 1 hour 39 minutes ago Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 10 hours 39 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 12 hours 34 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 12 hours 49 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 14 hours 24 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/22/2024 at 09:45, 53 minutes ago The GSMA – China Unicom Open Gateway Global Use Case Innovation Challenge has begun!
Published on 11/22/2024 at 09:23, 1 hour 15 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding issuance of subordinated notes
Published on 11/22/2024 at 09:06, 1 hour 32 minutes ago Original-Research: NFON AG (von NuWays AG): Buy
Published on 11/21/2024 at 06:58, 1 day 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo